Skip to main content

Publications

Featured publicationscd
  • Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII.

    Patient preference and adherence

    Authors: Susan Kearney, Leslie J Raffini, Tan P Pham, Xin Ying Lee, Sylvia von Mackensen, Andrea Landorph, Hideyuki Takedani, Johannes Oldenburg

    View this publication
  • Detailed methylation map of LINE-1 5'-promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity.

    Molecular genetics & genomic medicine

    Authors: Amit Sharma, Muhammad A Jamil, Nicole Nuesgen, Albertas Dauksa, Antanas Gulbinas, Wolfgang A Schulz, Johannes Oldenburg, Osman El-Maarri

    View this publication
  • Correction to: Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.

    Thrombosis journal

    Authors: Arshi Naz, Arijit Biswas, Tehmina Nafees Khan, Anne Goodeve, Nisar Ahmed, Nazish Saqlain, Shariq Ahmed, Ikram Din Ujjan, Tahir S Shamsi, Johannes Oldenburg

    View this publication
  • Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

    Journal of medicinal chemistry

    Authors: Charlotte A Bäuml, Thomas Schmitz, Ajay Abisheck Paul George, Monica Sudarsanam, Kornelia Hardes, Torsten Steinmetzer, Lori A Holle, Alisa S Wolberg, Bernd Pötzsch, Johannes Oldenburg, Arijit Biswas, Diana Imhof

    View this publication
  • Rapid and sustained immune tolerance to inhibitors induced by a plasma-derived, VWF-containing FVIII concentrate.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Elena Santagostino, Savita Rangarajan, Johannes Oldenburg, Roser Peiró-Jordan, Víctor Jiménez-Yuste

    View this publication
  • Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Rebecca Kruse-Jarres, Johannes Oldenburg, Elena Santagostino, Midori Shima, Christine L Kempton, Craig M Kessler, Michaela Lehle, Sammy Chebon, Nives Selak Bienz, Elina Asikanius, Johnny Mahlangu

    View this publication
  • Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.

    Hamostaseologie

    Authors: Martin Olivieri, Christoph Königs, Christine Heller, Silvia Horneff, Johannes Oldenburg, Susan Halimeh, Karim Kentouche, Ralf Knöfler, Lars Fischer, Christian Pfrepper, Karin Kurnik, Christoph Bidlingmaier

    View this publication
  • Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

    Haematologica

    Authors: Yohann Repessé, Catherine Costa, Roberta Palla, Elika Farrokhi Moshai, Annie Borel-Derlon, Roseline D'Oiron, Chantal Rothschild, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Johannes Oldenburg, Anna Pavlova, Frits R Rosendaal, Flora Peyvandi, Srinivas V Kaveri, Sébastien Lacroix-Desmazes

    View this publication
  • Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Stefan Schlabe, Kathrin van Bremen, Georg Goldmann, Johannes Oldenburg, Anna-Maria Eis-Hübinger, Heike Zeitler, Ulrich Spengler

    View this publication